These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36100654)

  • 1. Examining sex differences in responses to footshock stress and the role of the metabotropic glutamate receptor 5: an [
    Asch RH; Pothula S; Toyonaga T; Fowles K; Groman SM; Garcia-Milian R; DiLeone RJ; Taylor JR; Esterlis I
    Neuropsychopharmacology; 2023 Feb; 48(3):489-497. PubMed ID: 36100654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET imaging of mGluR5 in Alzheimer's disease.
    Mecca AP; McDonald JW; Michalak HR; Godek TA; Harris JE; Pugh EA; Kemp EC; Chen MK; Salardini A; Nabulsi NB; Lim K; Huang Y; Carson RE; Strittmatter SM; van Dyck CH
    Alzheimers Res Ther; 2020 Jan; 12(1):15. PubMed ID: 31954399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of Metabotropic Glutamate Receptor 5 Availability With Both [
    Glorie D; Verhaeghe J; Miranda A; De Lombaerde S; Stroobants S; Staelens S
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2022 Jun; 7(6):607-615. PubMed ID: 34856382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining mGlu5 Receptor Availability as a Predictor of Vulnerability to PTSD: An [
    Asch RH; Fowles K; Pietrzak RH; Taylor JR; Esterlis I
    Chronic Stress (Thousand Oaks); 2023; 7():24705470231215001. PubMed ID: 38024327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring the effects of ketamine on mGluR5 using [
    Holmes SE; Gallezot JD; Davis MT; DellaGioia N; Matuskey D; Nabulsi N; Krystal JH; Javitch JA; DeLorenzo C; Carson RE; Esterlis I
    J Cereb Blood Flow Metab; 2020 Nov; 40(11):2254-2264. PubMed ID: 31744389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excitotoxic neurodegeneration is associated with a focal decrease in metabotropic glutamate receptor type 5 availability: an in vivo PET imaging study.
    Crabbé M; Dirkx N; Casteels C; Laere KV
    Sci Rep; 2019 Sep; 9(1):12916. PubMed ID: 31501497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical Evaluation and Quantification of 18F-FPEB as a Radioligand for PET Imaging of the Metabotropic Glutamate Receptor 5.
    de Laat B; Leurquin-Sterk G; Celen S; Bormans G; Koole M; Van Laere K; Casteels C
    J Nucl Med; 2015 Dec; 56(12):1954-9. PubMed ID: 26405172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of influence of the glutamatergic concentration of [
    Dupont AC; Serrière S; Barantin L; Vercouillie J; Tauber C; Gissot V; Bodard S; Chicheri G; Chalon S; Bonnet-Brilhault PF; Santiago-Ribeiro PM; Arlicot N
    Transl Psychiatry; 2021 Jan; 11(1):66. PubMed ID: 33473111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two PET radioligands, [
    Lohith TG; Tsujikawa T; Siméon FG; Veronese M; Zoghbi SS; Lyoo CH; Kimura Y; Morse CL; Pike VW; Fujita M; Innis RB
    J Cereb Blood Flow Metab; 2017 Jul; 37(7):2458-2470. PubMed ID: 27629098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo variation in same-day estimates of metabotropic glutamate receptor subtype 5 binding using [
    DeLorenzo C; Gallezot JD; Gardus J; Yang J; Planeta B; Nabulsi N; Ogden RT; Labaree DC; Huang YH; Mann JJ; Gasparini F; Lin X; Javitch JA; Parsey RV; Carson RE; Esterlis I
    J Cereb Blood Flow Metab; 2017 Aug; 37(8):2716-2727. PubMed ID: 27742888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of age on brain metabotropic glutamate receptor subtype 5 measured with [
    Mecca AP; Rogers K; Jacobs Z; McDonald JW; Michalak HR; DellaGioia N; Zhao W; Hillmer AT; Nabulsi N; Lim K; Ropchan J; Huang Y; Matuskey D; Esterlis I; Carson RE; van Dyck CH
    Neuroimage; 2021 Sep; 238():118217. PubMed ID: 34052464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive Association Between Limbic Metabotropic Glutamate Receptor 5 Availability and Novelty-Seeking Temperament in Humans: An 18F-FPEB PET Study.
    Leurquin-Sterk G; Van den Stock J; Crunelle CL; de Laat B; Weerasekera A; Himmelreich U; Bormans G; Van Laere K
    J Nucl Med; 2016 Nov; 57(11):1746-1752. PubMed ID: 27283933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo characterization of metabotropic glutamate receptor type 5 abnormalities in behavioral variant FTD.
    Leuzy A; Zimmer ER; Dubois J; Pruessner J; Cooperman C; Soucy JP; Kostikov A; Schirmaccher E; Désautels R; Gauthier S; Rosa-Neto P
    Brain Struct Funct; 2016 Apr; 221(3):1387-402. PubMed ID: 25596865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic modeling and long-term test-retest reproducibility of the mGluR5 PET tracer 18F-FPEB in human brain.
    Leurquin-Sterk G; Postnov A; de Laat B; Casteels C; Celen S; Crunelle CL; Bormans G; Koole M; Van Laere K
    Synapse; 2016 Apr; 70(4):153-62. PubMed ID: 26799447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in Quantification of the Metabotropic Glutamate Receptor 5 Across Bipolar Disorder and Major Depressive Disorder.
    Holmes SE; Asch RH; Davis MT; DellaGioia N; Pashankar N; Gallezot JD; Nabulsi N; Matuskey D; Sanacora G; Carson RE; Blumberg HP; Esterlis I
    Biol Psychiatry; 2023 Jun; 93(12):1099-1107. PubMed ID: 36764853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered mGluR5 binding potential and glutamine concentration in the 6-OHDA rat model of acute Parkinson's disease and levodopa-induced dyskinesia.
    Crabbé M; Van der Perren A; Weerasekera A; Himmelreich U; Baekelandt V; Van Laere K; Casteels C
    Neurobiol Aging; 2018 Jan; 61():82-92. PubMed ID: 29055799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered metabotropic glutamate receptor 5 markers in PTSD: In vivo and postmortem evidence.
    Holmes SE; Girgenti MJ; Davis MT; Pietrzak RH; DellaGioia N; Nabulsi N; Matuskey D; Southwick S; Duman RS; Carson RE; Krystal JH; Esterlis I;
    Proc Natl Acad Sci U S A; 2017 Aug; 114(31):8390-8395. PubMed ID: 28716937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and preliminary biological evaluation of 3-[(18)F]fluoro-5-(2-pyridinylethynyl)benzonitrile as a PET radiotracer for imaging metabotropic glutamate receptor subtype 5.
    Wang JQ; Tueckmantel W; Zhu A; Pellegrino D; Brownell AL
    Synapse; 2007 Dec; 61(12):951-61. PubMed ID: 17787003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo metabotropic glutamate receptor type 5 abnormalities localize the epileptogenic zone in mesial temporal lobe epilepsy.
    Lam J; DuBois JM; Rowley J; González-Otárula KA; Soucy JP; Massarweh G; Hall JA; Guiot MC; Rosa-Neto P; Kobayashi E
    Ann Neurol; 2019 Feb; 85(2):218-228. PubMed ID: 30597619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of age/sex and the regional distribution of mGluR5 availability in the healthy human brain measured by high-resolution [(11)C]ABP688 PET.
    DuBois JM; Rousset OG; Rowley J; Porras-Betancourt M; Reader AJ; Labbe A; Massarweh G; Soucy JP; Rosa-Neto P; Kobayashi E
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):152-162. PubMed ID: 26290423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.